Поиcк препарата по названию

Motrin PM и почечная токсичность

Результат проверки взаимодействия лекарства Motrin PM и заболевания почечная токсичность на безопасность при совместном использовании.

Результат проверки:

Motrin PM <> почечная токсичность

Актуальность: 23.07.2019 Рецензент: Шкутко П.М., к.м.н., in

При проверке взаимодействия по данным авторитетных источников Drugs.com, Rxlist.com, Webmd.com, Medscape.com обнаружены противопоказания или побочные эффекты, которые могут нанести вред или усилить негативный эффект при использовании лекарства с данным сопутствующим заболеванием.

Потребитель:

Хроническое употребление нестероидных противовоспалительных препаратов (НПВП) могут быть связаны с почечной токсичности, в том числе повышения креатинина в сыворотке крови и булочка, тубулярный некроз, гломерулит, почечный папиллярный некроз, острый интерстициальный нефрит, нефротический синдром и почечная недостаточность. В пациентах с предварительно-почечная условиям которого почечной перфузии может зависеть от функции простагландинов, НПВС может спровоцировать развитие открытой почек декомпенсации через дозозависимым ингибированием синтеза простагландинов. Пациенты наибольшему риску этой реакции включают в себя пожилых пациентов и лиц с нарушенной функцией почек, сердечной недостаточности, дисфункция печени, или значительного объема и/или натрия истощения (например, из-за диуретиков). Терапия с НПВП следует назначать с осторожностью в таких больных, и гиповолемия и гипонатриемия должны быть исправлены до начала лечения. Клинический мониторинг почечной функции рекомендуется во время терапии, особенно при наличии проявлений связана с легкой азотемии (например, недомогание, усталость, потеря аппетита). Если снижение почечной функции или почечная недостаточность возникает, быстрое прекращение терапии НПВП обычно приводят к выздоровлению предварительной обработки состояние. НПВП, как правило, не рекомендуется для пациентов с тяжелой почечной недостаточности из-за отсутствия информации из контролируемых клинических исследований относительно их применения у таких пациентов.

Источники

Cefali EA, Poyner WJ, Sica D, Cox S "Pharmacokinetic comparison of flurbiprofen in end-stage renal disease subjects and subjects with normal renal function." J Clin Pharmacol 31 (1991): 808-14
Hannedouche T, Dehaine V, Noel LH, Jungers P "Acute tubular necrosis associated with acute pyelonephritis and concomitant diclofenac therapy ." Clin Nephrol 28 (1987): 103-4
Anttila M, Haataja M, Kasanen A "Pharmacokinetics of naproxen in subjects with normal and impaired renal function." Eur J Clin Pharmacol 18 (1980): 263-8
Katz SM, Capaldo R, Everts EA, DiGregorio JG "Tolmetin: association with reversible renal failure and acute interstitial nephritis." JAMA 246 (1981): 243-5
Shah GM, Muhalwas KK, Winer RL "Renal papillary necrosis due to ibuprofen." Arthritis Rheum 24 (1981): 1208-10
"Product Information. Daypro (oxaprozin)." Searle, Skokie, IL.
Jick H, Derby LE, Garcia Rodriguez LA, Jick SS, Dean AD "Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study." Pharmacotherapy 13 (1993): 212-7
Wattad A, Feehan T, Shepard FM, Youngberg G "A unique complication of nonsteroidal anti-inflammatory drug use." Pediatrics 93 (1994): 693
Kaufhold J, Wilkowski M, McCabe K "Flurbiprofen-associated acute tubulointerstitial nephritis." Am J Nephrol 11 (1991): 144-6
Mitnick PD, Klein WJ, Jr "Piroxicam-induced renal disease." Arch Intern Med 144 (1984): 63-4
Rubin A, Rodda BE, Warrick P, et al "Physiological disposition of fenoprofen in man II: plasma and urine pharmacokinetics after oral and intravenous administration." J Pharm Sci 61 (1972): 739-45
"Product Information. Celebrex (celecoxib)." Searle, Chicago, IL.
Chan LK, Winearls CG, Oliver DO, Dunnill MS "Acute interstitial nephritis and erythroderma associated with diflunisal." Br Med J 280 (1980): 84-5
Pazmino PA, Pazmino PB "Ketoprofen-induced irreversible renal failure." Nephron 50 (1988): 70-1
Whelton A, Bender W, Vaghaiwalla F, et al "Sulindac and renal impairment." JAMA 249 (1983): 2892-3
Fellner SK "Piroxicam-induced acute interstitial nephritis and minimal-change nephrotic syndrome." Am J Nephrol 5 (1985): 142-3
"Product Information. Indocin (indomethacin)." Merck & Co, Inc, West Point, PA.
Chan XM "Fatal renal failure due to indomethacin." Lancet 2 (1987): 340
Brater DC "Evaluation of etodolac in subjects with renal impairment." Eur J Rheumatol Inflamm 10 (1990): 44-55
Brier ME, Sloan RS, Aronoff GR "Population pharmacokinetics of the active metabolite of nabumetone in renal dysfunction." Clin Pharmacol Ther 57 (1995): 622-7
Radford RG, Holley KE, Grande JP, Larson TS, Wagoner RD, Donadio JV, Mccarthy JT "Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs." JAMA 276 (1996): 466-9
Verbeeck RK, Richardson CJ, Blocka KL "Clinical pharmacokinetics of piroxicam." J Rheumatol 13 (1986): 789-96
Stafanger G, Larsen HW, Hansen H, Sorensen K "Pharmacokinetics of ketoprofen in patients with chronic renal failure." Scand J Rheumatol 10 (1981): 189-92
Galler M, Folkert VW, Schlondorff D "Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy." JAMA 246 (1981): 154-5
Tietjen DP "Recurrence and specificity of nephrotic syndrome due to tolmetin." Am J Med 87 (1989): 354-5
Whelton A, Stout RL, Spilman PS, Klassen DK "Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure: a prospective, randomized, crossover comparison." Ann Intern Med 112 (1990): 568-76
Klassen DK, Stout RL, Spilman PS, Whelton A "Sulindac kinetics and effects on renal function and prostaglandin excretion in renal insufficiency." J Clin Pharmacol 29 (1989): 1037-42
"Product Information. Lodine (etodolac)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Schwarz A, Krause PH, Keller F, et al "Granulomatous interstitial nephritis after nonsteroidal anti-inflammatory drugs." Am J Nephrol 8 (1988): 410-6
Riegger GA, Kahles HW, Elsner D, Kromer EP, Kochsiek K "Effects of acetylsalicylic acid on renal function in patients with chronic heart failure." Am J Med 90 (1991): 571-5
Eriksson LO, Beermann B, Kallner M "Renal function and tubular transport effects of sulindac and naproxen in chronic heart failure." Clin Pharmacol Ther 42 (1987): 646-54
Schattenkirchner M "An updated safety profile of etodolac in several thousand patients." Eur J Rheumatol Inflamm 10 (1990): 56-65
Myles PS, Power I "Does ketorolac cause postoperative renal failure: how do we assess the evidence?" Br J Anaesth 80 (1998): 420-1
Rogers SY, Venning MC "Reversible acute renal failure precipitated by overdose of ibuprofen and salbutamol." Lancet 1 (1986): 737-8
Nortier J, Depierreux M, Bourgeois V, et al "Progression of a naproxen and amoxicillin induced acute interstitial nephritis with nephrotic syndrome: case report." Clin Nephrol 35 (1991): 187-9
Murray MD, Greene PK, Brater DC, et al "Effects of flurbiprofen on renal function in patients with moderate renal insufficiency." Br J Clin Pharmacol 33 (1992): 385-93
Marasco WA, Gikas PW, Azziz-Baumgartner R, et al "Ibuprofen-associated renal dysfunction: pathophysiologic mechanisms of acute renal failure, hyperkalemia, tubular necrosis, and proteinuria." Arch Intern Med 147 (1987): 2107-16
Kelley M, Bastani B "Ketorolac-induced acute renal failure and hyperkalemia." Clin Nephrol 44 (1995): 276-7
Feldman HI, Kinman JL, Strom BL "Acute renal failure and ketorolac." Ann Intern Med 127 (1997): 493-4
Artinano M, Etheridge WB, Stroehlein KB, Barcenas CG "Progression of minimal-change glomerulopathy to focal glomerulosclerosis in a patient with fenoprofen nephropathy." Am J Nephrol 6 (1986): 353-7
Wong F, Massie D, Hsu P, Dudley F "Indomethacin-induced renal dysfunction in patients with well- compensated cirrhosis." Gastroenterology 104 (1993): 869-76
"Product Information. Naprosyn (naproxen)." Syntex Laboratories Inc, Palo Alto, CA.
Davies NM "Clinical pharmacokinetics of flurbiprofen and its enantiomers." Clin Pharmacokinet 28 (1995): 100-14
Reeve PA, Moshiri M, Bell GD "Pulmonary oedema, jaundice and renal impairment with naproxen." Br J Rheumatol 26 (1987): 70-1
Carmichael J, Shankel SW "Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function." Am J Med 78 (1985): 992-1000
Gary NE, Dodelson R, Eisinger RP "Indomethacin-associated acute renal failure." Am J Med 69 (1980): 135-6
"Product Information. Mobic (meloxicam)" Boehringer-Ingelheim, Ridgefield, CT.
Poitirt TI "Reversible renal failure associated with ibuprofen: case report and review of the literature." Drug Intell Clin Pharm 18 (1984): 27-32
Brater DC, Brown-Cartwright D, Anderson SA, Uaamnuichai M "Effect of high-dose etodolac on renal function." Clin Pharmacol Ther 42 (1987): 283-9
"Product Information. Ansaid (flurbiprofen)." Pharmacia and Upjohn, Kalamazoo, MI.
Munn E, Lynn KL, Bailey RR "Renal papillary necrosis following regular consumption of non-steroidal anti-inflammatory drugs." N Z Med J 95 (1982): 213-4
Stierlin H, Faigle JW, Colombi A "Pharmacokinetics of diclofenac sodium (Voltaren) and metabolites in patients with impaired renal function." Scand J Rheumatol Suppl 22 (1978): 30-5
Fitzgerald GA, Patrono C "The coxibs, selective inhibitors of cyclooxsygenase-2." N Engl J Med 345 (2001): 433-42
"Product Information. Clinoril (sulindac)." Merck & Co, Inc, West Point, PA.
Haragsim L, Dalal R, Bagga H, Bastani B "Ketorolac-induced acute renal failure and hyperkalemia: report of three cases." Am J Kidney Dis 24 (1994): 578-80
Buck ML, Norwood VF "Ketorolac-induced acute renal failure in a previously healthy adolescent." Pediatrics 98 (1996): 294-6
Rudy AC, Figueroa NL, Hall SD, Brater DC "The pharmacokinetics of piroxicam in elderly persons with and without renal impairment." Br J Clin Pharmacol 37 (1994): 1-5
Feinfeld DA, Olesnicky L, Pirani CL, Appel GB "Nephrotic syndrome associated with use of the nonsteroidal anti-inflammatory drugs: case report and review of the literature." Nephron 37 (1984): 174-9
Berg KJ, Talseth T "Acute renal effects of sulindac and indomethacin in chronic renal failure." Clin Pharmacol Ther 37 (1985): 447-52
Caruana RJ, Semble EL "Renal papillary necrosis due to naproxen." J Rheumatol 11 (1984): 90-1
Delmas PD "Non-steroidal anti-inflammatory drugs and renal function." Br J Rheumatol 34 Suppl (1995): 25-8
Brezin JH, Katz SM, Schwartz AB, Chinitz JL "Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs." N Engl J Med 301 (1979): 1271-4
Boiskin I, Saven A, Mendez M, Raja RM "Indomethacin and the nephrotic syndrome." Ann Intern Med 106 (1987): 776-7
Selley ML, Glass J, Triggs EJ, Thomas J "Pharmacokinetic studies of tolmetin in man." Clin Pharmacol Ther 17 (1975): 599-605
Ling BN, Bourke E, Campbell WG, Delaney VB "Naproxen-induced nephropathy in systemic lupus erythematosus." Nephron 54 (1990): 249-55
Blackshear JL, Davidman M, Stillman MT "Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs." Arch Intern Med 143 (1983): 1130-4
Turner R "Hepatic and renal tolerability of long-term naproxen treatment in patients with rheumatoid arthritis." Semin Arthritis Rheum 17 (1988): 29-35
Colome Nafria E, Solans R, Espinach J, Delgadillo J, Fonollosa V "Renal papillary necrosis induced by flurbiprofen ." DICP 25 (1991): 870-1
Kimberly RP, Plotz PH "Aspirin-induced depression of renal function." N Engl J Med 296 (1977): 418-24
Whelton A "Renal effects of over-the-counter analgesics." J Clin Pharmacol 35 (1995): 454-63
Morgenstern SJ, Bruns FJ, Fraley DS, et al "Ibuprofen-associated lipoid nephrosis without interstitial nephritis." Am J Kidney Dis 14 (1989): 50-2
Wellborne FR, Claypool RG, Copley JB "Nephrotic range pseudoproteinuria in a tolmetin-treated patient." Clin Nephrol 19 (1983): 211-2
Jonsson CE, Ericsson F "Impairment of renal function after treatment of a burn patient with diclofenac, a non-steroidal anti-inflammatory drug." Burns 21 (1995): 471-3
Chatterjee GP "Nephrotic syndrome induced by tolmetin." JAMA 246 (1981): 1589
Sarma PS "Fatal acute renal failure after piroxicam." Clin Nephrol 31 (1989): 54
Bonney SL, Northington RS, Hedrich DA, Walker BR "Renal safety of two analgesics used over the counter: ibuprofen and aspirin." Clin Pharmacol Ther 40 (1986): 373-7
Aitken HA, Burns JW, McArdle CS, Kenny GNC "Effects of ketorolac trometamol on renal function." Br J Anaesth 68 (1992): 481-5
de Crespigny PJ, Becker GJ, Ihle BU, et al "Renal failure and nephrotic syndrome associated with sulindac." Clin Nephrol 30 (1988): 52-5
Verbeeck RK, De Schepper PJ "Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding." Clin Pharmacol Ther 27 (1980): 628-35
Turner GA, Walker RJ, Bailey RR, et al "Sulindac-induced acute interstitial nephritis." N Z Med J 97 (1984): 239-40
Boras-Uber LA, Brackett NC Jr "Ketorolac-induced acute renal failure." Am J Med 92 (1992): 450-2
Moss AH, Riley R, Murgo A, Skaff LA "Over-the-counter ibuprofen and nephrotic syndrome." Ann Intern Med 105 (1986): 303
Curt GA, Kaldany A, Whitley LG, et al "Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen calcium." Ann Intern Med 92 (1980): 72-3
Martinez JJ, Garg DC, Pages LJ, et al "Single dose pharmacokinetics of ketorolac in healthy young and renal impaired subjects." J Clin Pharmacol 27 (1987): 722
Vitting KE, Nichols NJ, Seligson GR "Naproxen and acute renal failure in a runner." Ann Intern Med 105 (1986): 144
van Biljon G "Reversible renal failure associated with ibuprofen in a child. A case report." S Afr Med J 76 (1989): 34-5
Boelaert JR, Jonnaert HA, Daneels RF, et al "Nabumetone Pharmacokinetics in patients with varying degrees of renal impairment." Am J Med 83 (1987): 107-9
Fong J, Gora ML "Reversible renal insufficiency following ketorolac therapy." Ann Pharmacother 27 (1993): 510-2
McCarthy JT, Torres VE, Romero JC, et al "Acute intrinsic renal failure induced by indomethacin." Mayo Clin Proc 57 (1982): 289-96
Buller GK, Perazella MA "Acute renal failure and ketorolac." Ann Intern Med 127 (1997): 493
Gerber D "Adverse reactions of piroxicam." Drug Intell Clin Pharm 21 (1987): 707-10
Quigley MR, Richfield M, Krumlovsky FA, et al "Concurrent naproxen and penicillamine-induced renal disease in rheumatoid arthritis." Arthritis Rheum 25 (1982): 1016-9
Blackwell E, Loughlin K, Dumler F, Smythe M "Nabumetone-associated interstitial nephritis." Pharmacotherapy 15 (1995): 669-72
Pearce CJ, Gonzalez FM, Wallin JD "Renal failure and hyperkalemia associated with ketorolac tromethamine." Arch Intern Med 153 (1993): 1000-2
Perazella MA, Buller GK "Can ibuprofen cause acute renal failure in a normal individual? A case of acute overdose." Am J Kidney Dis 18 (1991): 600-2
Pascoe MD, Gordon GD, Temple-Camp CR "Tolmetin-induced acute renal failure." S Afr Med J 70 (1986): 232-3
Perneger TV, Whelton PK, Klag MJ "Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs." N Engl J Med 331 (1994): 1675-9
Tattersall J, Greenwood R, Farrington K "Membranous nephropathy associated with diclofenac ." Postgrad Med J 68 (1992): 392-3
Eriksson L-O, Sturfelt G, Thysell H, Wollheim FA "Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis." Am J Med 89 (1990): 313-21
Beun GD, Leunissen KM, Van Breda Vriesman PJ, Van Hooff JP, Grave W "Isolated minimal change nephropathy associated with diclofenac." Br Med J (Clin Res Ed) 295 (1987): 182-3
Primack WA, Rahman SM, Pullman J "Acute renal failure associated with amoxicillin and ibuprofen in an 11-year-old boy." Pediatr Nephrol 11 (1997): 125-6
Shpilberg O, Douer D, Ehrenfeld M, et al "Naproxen-associated fatal acute renal failure in multiple myeloma." Nephron 55 (1990): 448-9
Gibson TP, Dobrinska MR, Lin JH, et al "Biotransformation of sulindac in end-stage renal disease." Clin Pharmacol Ther 42 (1987): 82-8
Singh G, Ramey DR, Morfeld D, Fries JF "Comparative toxicity of non-steroidal anti-inflammatory agents." Pharmacol Ther 62 (1994): 175-91
Loeffler M, Hanson G, Philp T "Piroxicam-induced renal failure following relief of chronic retention." Br J Urol 63 (1989): 438-9
Kharasch MS, Johnson KM, Strange GR "Cardiac arrest secondary to indomethacin-induced renal failure: a case report." J Emerg Med 8 (1990): 51-4
Brater DC, Anderson SA, Brown-Cartwright D, Toto RD, Chen A, Jacob GB "Effect of etodolac in patients with moderate renal impairment compared with normal subjects." Clin Pharmacol Ther 38 (1985): 674-9
Mitnick PD, Greenberg A, DeOreo PB, Weiner BM, Coffman TM, Walker BR, Agus ZS, Goldfarb S "Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney." Clin Pharmacol Ther 28 (1980): 680-9
"Product Information. Nalfon (fenoprofen)." Xspire Pharma, Ridgeland, MS.
Fong HJ, Cohen AH "Ibuprofen-induced acute renal failure with acute tubular necrosis." Am J Nephrol 2 (1982): 28-31
Schwartz J, Altshuler E, Madjar J, Habot B "Acute renal failure associated with diclofenac treatment in an elderly woman ." J Am Geriatr Soc 36 (1988): 482
Stierlin H, Faigle JW "Biotransformation of diclofenac sodium (Voltaren) in animals and man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile." Xenobiotica 9 (1979): 611-21
Helleberg L "Clinical pharmacokinetics of indomethacin." Clin Pharmacokinet 6 (1981): 245-58
Chiang ST, Morrison G, Knowles JA, Ruelius HW, Walker BR "Oxaprozin disposition in renal disease." Clin Pharmacol Ther 31 (1982): 509-15
Lomvardias S, Pinn VW, Wadhwa ML, et al "Nephrotic syndrome associated with sulindac." N Engl J Med 304 (1981): 424
Shand DG, Epstein C, Kinberg-Calhoun J, et al "The effect of etodolac administration on renal function in patients with arthritis." J Clin Pharmacol 26 (1986): 269-74
Quan DJ, Kayser SR "Ketorolac induced acute renal failure following a single dose." J Toxicol Clin Toxicol 32 (1994): 305-9
Audet PR, Knowles JA, Troy SM, Walker BR, Morrison G "Effect of chronic renal failure on oxaprozin multiple-dose pharmacokinetics." Clin Pharmacol Ther 44 (1988): 303-9
Handa SP "Drug-induced acute interstitial nephritis: report of 10 cases." Can Med Assoc J 135 (1986): 1278-81
Blouin R, Chaudhary I, Nishihara K, Cox S "The effects of liver and renal disease on stereoselective serum binding of flurbiprofen." Br J Clin Pharmacol 35 (1993): 62-4
Goebel KM, Mueller-Brodmann W "Reversible overt nephropathy with Henoch-Schonlein purpura due to piroxicam." Br Med J (Clin Res Ed) 284 (1982): 311-2
Segasothy M, Chin GL, Sia KK, Zulfiqar A, Samad SA "Chronic nephrotoxicity of anti-inflammatory drugs used in the treatment of arthritis." Br J Rheumatol 34 (1995): 162-5
Schwartzman M, D'Agati V "Spontaneous relapse of naproxen-related nephrotic syndrome." Am J Med 82 (1987): 329-32
"Product Information. Voltaren (diclofenac)." Novartis Pharmaceuticals, East Hanover, NJ.
"Product Information. Motrin (ibuprofen)." Pharmacia and Upjohn, Kalamazoo, MI.
Zawada ET "Renal consequences of nonsteroidal antiinflammatory drugs." Postgrad Med J 71 (1982): 223-30
"Product Information. Orudis (ketoprofen)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Brater DC, Anderson SA, Brown D "Reversible acute decrease in renal function by NSAIDs in cirrhosis." Am J Med Sci 294 (1987): 168-74
Dickinson RG, Verbeeck RK, King AR, Restifo AC, Pond SM "Diflunisal and its conjugates in patients with renal failure." Br J Clin Pharmacol 31 (1991): 546-50
Alvan G, Orme M, Bertilsson L, et al "Pharmacokinetics of indomethacin." Clin Pharmacol Ther 18 (1975): 364-73
Watson WA, Freer JP, Katz RS, Basch C "Kidney function during naproxen therapy in patients at risk for renal insufficiency." Semin Arthritis Rheum 17 (1988): 12-6
Cangiano JL, Figueroa J, Palmer R "Renal hemodynamic effects of nabumetone, sulindac, and placebo in patients with osteoarthritis." Clin Ther 21 (1999): 503-12
Richardson CJ, Blocka KL, Ross SG, Verbeeck RK "Piroxicam and 5'-hydroxypiroxicam kinetics following multiple dose administration of piroxicam." Eur J Clin Pharmacol 32 (1987): 89-91
Ogawa M, Ueda S, Hamano Y, Ito K, Saisho H, Akikusa B "Membranous nephropathy associated with oxaprozin treatment." Nephron 74 (1996): 439-40
Maher JF "Analgesic nephropathy. Observations, interpretations, and perspective on the low incidence in America." Am J Med 76 (1984): 345-8
Blackshear JL, Davidman M, Stillman MT "Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs." Arch Intern Med 143 (1983): 1130-4
Hyneck ML "An overview of the clinical pharmacokinetics of nabumetone." J Rheumatol 19 (1992): 20-4
"Product Information. Vioxx (rofecoxib)." Merck & Co, Inc, West Point, PA.
Wolf G, Porth J, Stahl RA "Acute renal failure associated with rofecoxib." Ann Intern Med 133 (2000): 394
"Product Information. Feldene (piroxicam)." Pfizer US Pharmaceuticals, New York, NY.
Wendland ML, Wagoner RD, Holley KE "Renal failure associated with fenoprofen." Mayo Clin Proc 55 (1980): 103-7
Frais MA, Burgess ED, Mitchell LB "Piroxicam-induced renal failure and hyperkalemia." Ann Intern Med 99 (1983): 129-30
Kagan A, Nissim F, Green L, Bar-Khayim Y "Scleroderma renal crisis without hypertension." J Rheumatol 16 (1989): 707-8
"Product Information. Relafen (nabumetone)." SmithKline Beecham, Philadelphia, PA.
"Product Information. Bextra (valdecoxib)." Pharmacia Corporation, Peapack, NJ.
Rossi E, Ferraccioli GF, Cavalieri F, Menta R, Dall'Aglio PP, Migone L "Diclofenac-associated acute renal failure. Report of 2 cases." Nephron 40 (1985): 491-3
Feldman HI, Kinman JL, Berlin JA, et al. "Parenteral ketorolac: the risk for acute renal failure." Ann Intern Med 126 (1997): 193-9
Sennesael J, Van den Houte K, Verbeelen D "Reversible membranous glomerulonephritis associated with ketoprofen." Clin Nephrol 26 (1986): 213-5
"Product Information. Dolobid (diflunisal)." Merck & Co, Inc, West Point, PA.
Ravis WR, Diskin CJ, Campagna KD, Clark CR, McMillian CL "Pharmacokinetics and dialyzability of sulindac and metabolites in patients with end-stage renal failure." J Clin Pharmacol 33 (1993): 527-34
"Product Information. Tolectin (tolmetin)." McNeil Pharmaceutical, Raritan, NJ.
Bergamo RR, Cominelli F, Kopple JD, Zipser RD "Comparative acute effects of aspirin, diflunisal, ibuprofen and indomethacin on renal function in healthy men." Am J Nephrol 9 (1989): 460-3